NCT06964737
- Conditions
- Glioma, Neoplasms, Neoplasms by Histologic Type, +11 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Clinical trial condition
Recurrent WHO Grade 3 Glioma
Explore clinical trials studying Recurrent WHO Grade 3 Glioma. Study availability and eligibility vary by location and protocol.
3 public trials
2 recruiting studies
Recurrent WHO Grade 3 Glioma trial results
Recruiting
Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma
NCT06410248
- Conditions
- Astrocytoma, Glioblastoma, Glioma, +11 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
Active, not recruiting
Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment
NCT05859334
- Conditions
- Glioma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- UCHealth University of Colorado Hospital Aurora, Colorado, United States
- UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables, Florida, United States
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach, Florida, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States